The Fifth Universal Definition of Myocardial Infarction moves beyond traditional diagnostic categories to distinguish the underlying mechanisms of cardiac injury. Its potential to improve the recognition and management of myocardial infarction in women is substantial, but better classification must translate into better treatment and clinical outcomes
A heart attack is not always caused by a blocked coronary artery, and elevated cardiac troponin does not necessarily indicate myocardial infarction. These distinctions underpin the Fifth Universal Definition of Myocardial Infarction, published in 2026 by Mills and colleagues on behalf of four major international cardiovascular societies [1]. The consensus replaces the previous numerical classification with three clinically defined categories: primary, secondary and procedure-related myocardial infarction.
The revision is more than a change in terminology. By aligning diagnosis with underlying pathophysiology, it seeks to address inconsistencies that have complicated clinical decision-making, treatment selection and cardiovascular research. Its implications may be particularly important for women, among whom myocardial infarction has historically been under-recognized and certain coronary mechanisms are disproportionately represented.
Recognizing different mechanisms of myocardial infarction
Under the previous classification, spontaneous coronary artery dissection, coronary vasospasm and coronary embolism were grouped within type 2 myocardial infarction alongside ischemia caused by systemic conditions such as severe anemia or tachyarrhythmia. Yet these processes differ substantially in pathophysiology and management.
The new definition distinguishes primary myocardial infarction, arising from acute coronary pathology, from secondary myocardial infarction, resulting from oxygen supply–demand imbalance triggered by another acute condition. Infarction following a complication of a cardiac intervention is classified separately.
This distinction could be particularly consequential for younger women and those experiencing myocardial infarction during pregnancy or the postpartum period, when spontaneous coronary artery dissection warrants specific consideration. Unlike atherothrombotic myocardial infarction, which may require urgent coronary intervention and antithrombotic treatment, clinically stable coronary dissection is frequently managed conservatively [4].
Identifying the mechanism, rather than treating every infarction as a manifestation of plaque rupture, creates an opportunity to select interventions according to their likely benefits and risks.
Correcting diagnostic bias in women
One of the most consequential features of the revised definition is its explicit use of sex-specific 99th-percentile upper reference limits for cardiac troponin to define myocardial injury.
Women generally have lower circulating troponin concentrations than men. Consequently, uniform diagnostic thresholds can fail to recognize myocardial injury in women whose concentrations exceed the appropriate female reference limit but remain below the pooled threshold.
Sex-specific thresholds were already recommended in the Fourth Universal Definition in 2018. The new consensus strengthens their role in the formal diagnostic criteria, emphasizing that their application is necessary to avoid systematic under-recognition.
However, greater diagnostic sensitivity is not equivalent to improved outcomes.
In the randomized High-STEACS study involving 48,282 patients, implementation of a high-sensitivity troponin assay with sex-specific thresholds increased the identification of myocardial injury by 42% in women, compared with 6% in men. Nevertheless, women remained substantially less likely to undergo coronary revascularization or receive treatments for coronary artery disease. The intervention did not significantly reduce recurrent myocardial infarction or cardiovascular death at one year [2].
These findings expose a critical limitation of diagnostic innovation: recognition alone cannot improve prognosis unless it changes clinical management appropriately.
The new definition also discourages describing symptoms as typical or atypical. Chest discomfort remains the most common presenting symptom in both sexes, but women more frequently report accompanying breathlessness, nausea or pain between the shoulder blades. More systematic symptom assessment could reduce diagnostic delays without reinforcing the misleading assumption that women usually experience heart attacks without chest pain.
Beyond obstructive coronary disease
The revision also changes the meaning of MINOCA, retaining the acronym but redefining it as myocardial injury with non-obstructive coronary arteries, rather than myocardial infarction.
This distinction recognizes MINOCA as a provisional diagnosis requiring further evaluation, not a final determination of irreversible ischemic injury.
Its clinical significance is considerable. A patient with elevated troponin and non-obstructive coronary arteries may have an acute coronary mechanism, but myocarditis, Takotsubo syndrome or another condition may explain the presentation. These diagnoses require different management strategies.
Evidence supporting further investigation has recently strengthened. In a prospective multicentre study published in 2026, Reynolds and colleagues used optical coherence tomography and cardiac magnetic resonance imaging to investigate suspected MINOCA in women and men. Combined imaging established an underlying cause in 79% of patients who completed both investigations. An ischemic mechanism was identified in 59%, whereas 20% had a non-ischemic condition mimicking myocardial infarction. No significant sex differences in imaging findings were detected [3].
These findings challenge the assumption that non-obstructive coronary arteries exclude clinically important cardiac disease. They also support a mechanism-oriented diagnostic pathway in which targeted imaging may distinguish patients who require coronary treatment from those needing alternative care.
The revised criteria for secondary myocardial infarction similarly prioritize specificity. Acute troponin elevation in the setting of severe systemic illness is insufficient on its own to establish infarction. When feasible and appropriate, objective coronary or cardiac imaging evidence can help distinguish ischemic myocardial damage from other forms of injury.
Such differentiation may limit unnecessary treatment while identifying clinically actionable coronary disease or ventricular dysfunction.
From diagnostic precision to improved outcomes
The greatest unresolved question is whether more accurate classification will improve patient outcomes.
The consensus provides a stronger framework for decision-making, but it is not itself evidence that the proposed changes reduce mortality, recurrent infarction or disability. Increased use of advanced imaging also introduces potential barriers related to cost, availability and access to specialized cardiovascular services.
An additional opportunity lies in the proposed alignment with ICD-11 classification. More precise coding of infarction mechanisms could improve cardiovascular surveillance, enable sex-stratified comparisons and strengthen the validity of clinical trial populations. However, the proposed coding framework requires effective implementation before these benefits can be realized.
Future evaluations should therefore measure more than changes in diagnostic frequency. They should establish whether adoption of the definition improves time to diagnosis, appropriate imaging, mechanism-specific treatment, secondary prevention and cardiac rehabilitation. Most importantly, studies should examine absolute differences in recurrent cardiovascular events, mortality and patient-reported outcomes, with sufficient statistical power to identify clinically meaningful sex-related disparities.
For women, closing the diagnostic gap is necessary but insufficient. More sensitive biomarkers, clearer diagnostic criteria and better recognition of non-atherothrombotic coronary mechanisms can identify patients who might otherwise be overlooked. Their value ultimately depends on whether clinicians act on these findings with interventions that are appropriate to the underlying condition.
The defining advance of the Fifth Universal Definition may therefore be its shift from identifying myocardial infarction to understanding why it occurred. Whether this delivers better outcomes, particularly for women, will depend on how effectively that understanding is translated into care.
References
1. Mills, N. L. et al. Fifth Universal Definition of Myocardial Infarction (2026). J. Am. Coll. Cardiol. 88, 1314–1368 (2026). https://doi.org/10.1016/j.jacc.2026.07.025
2. Lee, K. K. et al. Sex-specific thresholds of high-sensitivity troponin in patients with suspected acute coronary syndrome. J. Am. Coll. Cardiol. 74, 2032–2043 (2019). https://doi.org/10.1016/j.jacc.2019.07.082
3. Reynolds, H. R. et al. Multimodality imaging to determine underlying causes of myocardial infarction with nonobstructive coronary arteries in women and men. Circulation 153, 1606–1622 (2026) https://doi.org/10.1161/CIRCULATIONAHA.126.080234
4. Virani, S. S. et al. 2023 AHA/ACC multisociety guideline for the management of patients with chronic coronary disease. J. Am. Coll. Cardiol. 82, 833–955 (2023). https://doi.org/10.1016/j.jacc.2023.04.003

